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Abstract 
Near-infrared (NIR) fluorescence imaging in the 700-1000 nm wavelength range has 
been very attractive for early detection of cancers. Conventional NIR dyes often suffer 
from limitation of low brightness due to self-quenching, insufficient photo- and 
bioenvironmental stability, and small Stokes shift. Herein, we present a strategy of 
using small-molecule organic dye nanoparticles (ONPs) to encapsulate NIR dyes to 
enable efficient fluorescence resonance energy transfer to obtain NIR probes with 
remarkably enhanced performance for in vitro and in vivo imaging. In our design, host 
ONPs are used as not only carriers to trap and stabilize NIR dyes, but also 
light-harvesting agent to transfer energy to NIR dyes to enhance their brightness. In 
comparison with pure NIR dyes, our organic dye nanoparticles possess almost 50-fold 
increased brightness, large Stokes shifts (~250 nm) and dramatically enhanced 
photostability. With surface modification, these NIR-emissive organic nanoparticles 
have water-dispersity and size- and fluorescence- stability over pH values from 2 to 
10 for almost 60 days. With these superior advantages, these NIR-emissive organic 
nanoparticles can be used for highly efficient folic-acid aided specific targeting in vivo 
and ex vivo cellular imaging. Finally, during in vivo imaging, the nanoparticles show 
negligible toxicity. Overall, the results clearly display a potential application of using 
the NIR-emissive organic nanoparticles for in vitro and in vivo imaging. 
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1. Introduction 
In near-infrared (NIR) spectral range, organisms and tissues have low absorption 
of light and possess low intrinsic autofluorescence. Autofluorescence is the natural 
emission of light from biological structures. If biomarkers are fluorescent in NIR 
range, they can be better detected and identified from the surrounding biological 
environment. Therefore, NIR fluorescence imaging in wavelength range of 700-1000 
nm is particularly attractive for early detection of cancers, which is expected to 
significantly contribute to improved cancer therapy and increased survival rates of 
patients [1-4].  
Currently, the most widely used NIR probes are still organic dyes, which are 
usually encapsulated in various nanoparticles (NPs) to overcome the intrinsic 
limitations of conventional NIR dyes including poor hydrophilicity, low photostability, 
small quantum yield (QY) and instability in bio-environment [5-8]. However, most of 
these encapsulating nanoparticles including silica NPs, calcium phosphate NPs, and 
lipoprotein NPs, only act as inert carriers but do not contribute to brightness 
improvement of the NIR probes [9-12]. Another concern is that Stokes shift of 
conventional nanoparticle-based dye probes is usually small and optical interferences 
(light scattering and autofluorescence) caused by biosubstrates often exist, which 
greatly reduces detection sensitivity [13]. Furthermore, the clearance of inert carriers 
from patients still remains a great concern. Conjugated polymer dots (Pdots) were 
then reported to be utilized as the matrix to load organic dyes for imaging, in which 
Pdots served as light-harvesting agents to transfer their energy to organic dyes to 
enhance brightness [14-15].  
Recently, small-molecule organic dye nanoparticles (SM ONPs) have also been 
developed as a new class of promising fluorescent probes [16-19], where organic dyes 
themselves were directly assembled into pure dye nanoparticles without nanocarriers. 
Despite at early stage, SM ONPs have attracted much attention, because they possess 
large absorption cross-sections, non-blinking property and favorable biocompatibility. 
More importantly, compared to Pdots, there is great variety and flexibility in materials 
design and thus tunability in optical properties and functionalities [20-21]. Previously, 
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dye molecules with rigid structures or aggregation-induced enhanced emission (AIEE) 
properties were used for preparing SM ONPs to avoid concentration quenching of 
traditional dyes [22]. For example, recently, we reported a type of ultrabright and 
ultrastable NIR dye nanoparticles which were prepared from a NIR dye of 
bis(4-(N-(2-naphthyl)phenylamino) phenyl)-fumaronitrile (NPAPF) with AIEE effect 
[16]. However, if traditional NIR dyes are employed to make nanoparticles, severe 
quenching will happen. 
To address the challenges of developing NIR fluorescence probes with high 
brightness, large Stokes shift and photo- and bio-environmental stability, herein, we 
encapsulated an NIR dye into red-emissive ONPs. We hypothesize that the efficient 
fluorescence resonance energy transfer (FRET) from ONPs to NIR dyes will enable 
the resultant NPs to possess superior properties for bioimaging. To confirm this, we 
systematically investigated the optical properties, water-dispersity, photo- and 
bio-environmental stability and in vivo toxicity of the NIR dye doped NPs and tested 
their application for in vitro and in vivo imaging. 
 
2. Experimental Section 
2.1. Materials and characterization  
 NIR712 dye (2,9,16,23-tetra-tert-butyl-29H,31H-phthalocyanine) was 
purchased from Sigma Aldrich, Inc. Tetrahydrofuran (THF) was ordered from 
Shanghai LingFeng Chemical Reagent Co., Ltd. High-purity water (resistivity = 18.2 
MΩ cm) was produced with a Milli-Q apparatus (Millipore). Fetal bovine serum 
(FBS), Roswell Park Memorial Institute-1640 (RPMI-1640) medium, folic acid 
(FA)-free RPMI-1640 and Penicillin-streptomycin solution were obtained from 
Invitrogen (San Diego, CA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), dimethyl sulfoxide (DMSO) and poly(maleic 
anhydride-alt-1-octadecene) (C18PMH) were from Sigma Aldrich (Milwaukee, WI). 
4’,6-diamidino-2-phenylindole (DAPI) and LysoTracker Green DND-26 were 
purchased from Invitrogen. Triethylamine (TEA) and mPEG-NH2 (5k) were from 
Sinopharm Chemical Reagent Co. and PegBio (Suzhou, China), respectively. 
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N-hydroxysuccinimide (NHS) and 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC) were ordered from Fluka. A human nasopharyngeal epidermal carcinoma cell 
line (KB cell), a human epithelial cervical cancer cell line (HeLa cell), a human fetal 
lung fibroblast MRC-5 cell line (MRC-5 cell) and a 4T1 murine breast cancer cell line 
(4T1 cell) were provided by American Type Culture Collection (ATCC).  
UV-Vis absorption spectra were obtained on a Perkin-Elmer Lambda 750 
UV/Vis/NIR spectrometer. Fluorescence spectra were measured with a Horiba Jobin 
Yvon luminescence spectrometer (FluoroMax 4). Scanning electron microscopy 
(SEM) images were taken with a FEI Quanta 200 FEG field emission scanning 
electron microscope. Transmission electron microscopy (TEM) images were taken by 
FEI Tecnai G2 F20 S-TWIN. Dynamic light scattering (DLS) measurements were 
carried out on a Zetasizer Nano ZS (Malvern Instruments, Malvern, U.K.). All 
measurements were performed at room temperature. 
 
2.2. Synthesis of NPAFN 
2,3-bis(4'-(diphenylamino)-[1,1'-biphenyl]-4-yl)fumaronitrile (NPAFN) was 
prepared according to previously reported procedures [23]. A mixture of 
4-bromophenylacetonitrile (4.86 g, 24.8 mmol) and iodine (6.35 g, 25 mmol) was 
purged with N2 and dry diethyl ether (100 mL) was injected to the mixture with a 
needle and syringe. Then the temperature of the solution was dropped to -78 °C. 
Sodium methoxide (2.84 g, 52.6 mmol) and methanol (40 mL) were subsequently 
slowly added within a period of over 30 min following by stirring for 40 min. Next, 
the solution was placed in an ice-water bath for 4 hours under stirring. Then, 3-6% 
hydrochloric acid was added dropwisely and the solution was filtered to separate the 
precipitate. After it, the precipitate was rinsed with cold methanol-water solvent and 
the filtrate was concentrated to obtain the second crop of product. Through these 
procedures, a pale yellow solid was obtained with a yield of greater than 90%.  
A mixture of bis(4-bromophenyl)fumaronitrile (0.787 g, 2.03 mmol), 
triphenylamine (4.47 mmol), Cs2CO3 (1.95 g, 5.98 mmol) and toluene (13 mL) was 
degassed and purged with N2. Pd/P(t-Bu)3 catalyst pre-prepared from Pd(OAc)2 
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(0.0135 g, 0.06 mmol), P(t-Bu)3 (0.36 g, 0.178 mmol) and toluene (4 mL) was added 
to the mixture inside a glove box. The reaction mixture was then degassed, purged 
with nitrogen, heated to 110 °C and maintained for 24 h. The mixture was cooled to 
room temperature followed by adding water (30 mL) and dichloromethane (50 mL). 
The organic layer was separated and washed with brine, dried over anhydrous MgSO4 
and evaporation under reduced pressure. Finally, the product was purified by column 
chromatography on silica gel using 1:1 lightpetroleum/dichloromethane as eluant to 
afford NPAFN (1.036g) as orange solid. Melting point (oC): 249.8-250.5. 1H NMR 
(400 MHz, CDCl3, δ, ppm): 7.93 (d, 4H), 7.73 (d, 4H), 7.53 (d, 4H), 7.30 (t, 8H), 7.16 
(d, 12H), 7.08 (t, 4H). 13C NMR (400 MHz, CDCl3, δ, ppm): 148.64, 147.43, 143.63, 
132.54, 130.33, 129.94, 129.41, 129.28, 127.86, 127.67, 127.04, 126.87, 124.89, 
124.01, 123.45, 123.20, 117.03, 77.23, 77.19, 77.17. MS (C52H36N4): calcd, 716.87; 
found, 716.29. 
 
2.3. Synthesis of folic acid conjugated C18PMH-PEG (C18PMH-PEG-FA) 
C18PMH-PEG was synthesized as stated in literature [24]. To prepare 
C18PMH-PEG-FA, C18PMH-PEG was firstly functionalized with amine group. In 
detail, C18PMH (1eq), mPEG-NH2 (5k) (1eq) and NH2-mPEG(5k)-BOC (Polymere, 
Germany) (0.5eq) were mixed in dichloromethane under agitation. EDC (2eq) and 
TEA (8eq) were then added to the solution under magnetic stirring. After stirring for 
24 h at room temperature, the dichloromethane solvent was blown dry with a N2 flow. 
Subsequently, 2 mL of trifuoroacetic acid was added and actively stirred for 3 h at 
room temperature to de-protect the Boc group. After the evaporation of the TFA 
solvent, the residual solid was dissolved in water, which was dialyzed for 2 days in a 
dialysis bag (MWCO = 14 kDa) to remove unreacted PEG polymers and other 
reagents. After lyophilization, the final product (C18PMH-PEG-NH2) in white solid 
was stored at -20 °C for future use. 
The folic acid conjugated C18PMH-PEG was prepared by conjugating the 
amine-functionalized C18PMH-PEG-NH2 with activated FA. Briefly, 35 mg of FA 
was mixed with 15 mg EDC and 23 mg NHS in 5 mL of anhydrous DMSO for 15 min 
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at room temperature. 20 mg of C18PMH-PEG-NH2 in 5 mL of DMSO was added 
afterwards (molar ratio of NH2/FA/EDC/NHS = 1:2:2:5). After stirring at room 
temperature for 8 h, water was added and the product was purified by dialysis. The 
final product was lyophilized and stored at -20 °C until use. 
 
2.4. Preparation and functionalization of NIR712-doped NPs 
NIR712-doped NPs were synthesized through a facile solvent exchange 
approach. NPAFN was first dissolved in THF to prepare a 1 × 10-3 M stock solution. 
Different amounts of NIR712 dye were added to 0.15 mL of the stock solutions. The 
mixed solutions were each injected to 5 mL of aqueous solution at 30 °C under 
vigorous stirring at 1000 rpm. After stirring for 3 min, the samples were stabilized for 
24 hours. 
For modification of NIR712-doped NPs, 2 mg of C18PMH-PEG was dispersed 
in 10 mL of water by sonication. Then 300 µL of solution was added into 5 mL of 
NPs suspensions followed by ultrasonication for 5 min. After that, solution was kept 
for use at room temperature. C18PMH-PEG-FA functionalization was executed 
referring to the former. To evaluate the stability of the NPs, evolutions of their 
diameter and fluorescence in phosphate buffered saline (PBS), serum and 
Na2CO3-NaHCO3, Na2HPO4-Citric acid buffer solution of different pH values were 
recorded at different times. All measurements were performed at room temperature. 
 
2.5. Determination of quantum yield  
Fluorescence quantum yield was measured using a Perkin-Elmer Lambda 750 
UV/Vis/NIR Spectrometer and luminescence spectrometer. We made use of 
2,7-di(4-(diphenylamino)phenyl-2,1,3-benzothiadiazol-7-yl)-9,9’-spirobifluorene 
(Spiro-BTA) excited at 468 nm (QY = 0.45) as a standard to measure the fluorescence 
quantum yields of NIR712-doped NPs in suspensions. Quantum yield was calculated 
according to the following equation:  
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η, A, I and n refer to quantum yield, absorbance, fluorescent intensity and refractive 
indices, respectively. The subscripts s and r refer to the sample and the reference 
solutions respectively. In our experiments, Ar = 0.05, As = 0.05, ns = 1.333 (H2O, 
20 °C), nr = 1.4 (THF, 20 °C). It was obtained by integrating the emission spectra over 
680-850 nm for NIR712-doped NPs. 
 
2.6. Cell culture 
KB cells were cultured in folic acid free RPMI-1640 and normal RPMI-1640 
supplemented with 10% FBS and 1% penicillin/streptomycin solution at 37 °C in a 
humidiﬁed atmosphere containing 5% CO2. The former was considered as a positive 
group and the latter as a negative group. 4T1 cells, MRC-5 cells and HeLa cells were 
cultured in normal RPMI-1640 supplemented with 10% FBS and 1% 
penicillin/streptomycin at 37 °C in a humidiﬁed atmosphere containing 5% CO2. 
 
2.7. Cytotoxicity assays  
KB, MRC-5 and HeLa cell lines were grown into a 96-well cell-culture plate at 
104-105/well and then incubated for 24 hours at 37 °C under 5% CO2. After incubating 
the cells with different doses of NPs, the standard MTT assay was performed to 
measure the cell viabilities by using untreated cells as a control. In this paper, all of 
the error bars indicate the standard deviation (SD) of the results. 
 
2.8. In vitro fluorescence imaging  
For the FA targeted imaging experiment, both positive and negative cells were 
incubated with 3 µM C18PMH-PEG or C18PMH-PEG-FA modified NPs for 3 hours 
at 37 °C. Cells were dually labeled with blue-colored nuclei-specific DAPI and 
green-colored lysosome-specific Green DND-26 before observation. Confocal 
imaging of the cells was carried out with 488 nm laser excitation and emission was 
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measured from 680 to 800 nm. All cells were washed twice with cell culture medium 
before imaging. A flow cytometer (FACS Calibur from Becton, Dickinson and 
Company) was used for quantitative analysis. 
 
2.9. In vivo fluorescence imaging  
KB tumor-bearing mice were intravenously injected with 200 μL of 100 μM 
PEGylated NIR712-doped NPs and imaged using a Maestro in vivo fluorescence 
imaging system (CRi Inc.). The mice were excited with a blue light peaked at 455 nm. 
In vivo spectral imaging from 700 to 850 nm (10 nm step) was then carried out. 
 
2.10. Biodistribution 
Tumor-bearing mice (4T1) injected with PEGylated NIR712-doped NPs were 
sacrificed at 1, 6, 12, 24, and 48 hours after injection. Major organs and tumor tissue 
were then spectrally imaged by the Maestro system. The average intensity of the 
PEGylated NP fluorescence was calculated for a semi-quantitative biodistribution 
analysis. 
 
2.11. Histology analysis  
Untreated control mice and the mice which were injected with 200 μL of 100 μM 
PEGylated NIR712-doped NPs were sacrificed at Day 1, 7 and 14 after treatment. 
Major organs of the mice were collected, fixed in 10% of neutral buffered formalin, 
processed in paraffin, sectioned with a thickness of 8 μm, stained with hematoxylin 
and eosin (H&E), and finally examined by a digital microscope (Leica QWin). The 
investigated organs included liver, spleen, kidney, heart and lung. 
 
2.12. Blood analysis  
Three healthy Balb/c mice were injected with 200 μL of 100 μM PEGylated 
NIR712-doped NPs. The other three mice were used as the untreated control. At Day 
1, 7 and 14 after NP injection, the mice were sacrificed and blood was collected for 
blood biochemistry assay and complete blood panel test, which were performed in 
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Shanghai Research Center for Biomodel Organism. 
 
3. Results and discussion 
3.1. Synthesis and characterization of NIR712-doped NPs 
NPAFN ONPs with characteristic of aggregation-induced enhanced emission 
were chosen as encapsulating red-emissive NPs, and a non-water soluble NIR712 was 
selected as doping NIR dye. The molecular structures of NPAFN and NIR712 are 
shown in Fig. S1. Reason of the choice is that the photoluminescence (PL) spectrum 
of NPAFN ONPs overlaps well with the absorption spectrum of NIR712 (Fig. S3), 
which ensures efficient energy transfer in the guest-host systems and thus leads to 
enhanced optical properties. 
NIR712-doped NPs were prepared by a simple solvent exchanging method 
[24-25]. Mixtures of NPAFN and NIR712 of different ratios in THF were injected into 
water under vigorous stirring. Due to a sudden change of solvent environment, 
NPAFN molecules aggregated and precipitated out to form NPs. During the process, 
NIR712 molecules were encapsulated into/onto the NPAFN NPs. SEM image (Fig. 1a) 
shows that the NIR712-doped NPs have roughly spherical structures with an average 
diameter of about 110 nm. The inset of Fig. 1a shows the TEM image of the 
NIR-doped NPs. In addition, dynamic laser light scattering (DLS) (Fig. 1b) 
measurement indicates that the NPs have an average diameter of about 118 nm and 
narrow size distribution (Polydispersity Index (PDI) = 0.107), which is consistent 
with the microscopy observation. In order to verify that NIR712 molecules were 
successfully encapsulated within the host NPs and not easily leaked out, we put the 
doped NP solution into a 30 k molecular weight cutoff centrifugal membrane, which 
only allows free NIR712 dyes to pass through. After filtration, the UV-Vis and PL 
spectra of the filtrate were measured. The results suggest that there were negligible 
free NIR712 molecules in the filtrate, which indicates that NIR712 molecules were 
successfully encapsulated into or onto the hydrophobic host material with high 
stability (Fig. S2). 
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3.2. Optical properties of NIR712-doped NPs 
    Upon doping of NIR712, emission from the original NPAFN NPs was effectively 
quenched and replaced with the emission from NIR712 (Fig. 1d), indicating efficient 
energy transfer from the host NPs to the dyes. With doping concentration increases, 
the emission intensity of NIR712 was observed to reach maximum value at a 
concentration of 0.25% (molar ratio of NPAFN : NIR712 = 1 : 0.25%) and then 
gradually drop down. At the optimal doping concentration of 0.25% NIR712, the QY 
is 1.8%. 
 
3.3. The process of energy transfer and amplified fluorescence emission 
It was reported that the doping process is a kind of classic föster energy transfer 
process, which should fit to Stern-Volmer equation 0 / 1 *[ ]SVF F K A  , where F0 
and F represent the fluorescence intensity in the absence and presence of quencher 
respectively [26]. The value [A] represents the concentration of the quencher, and KSV 
is the Stern-Volmer quenching constant, which is obtained from the slope of a linear 
fit to a plot of F0/F versus [A]. If the acceptor concentration represents a molecule 
fraction, KSV indicates the number of host molecules which are quenched by an 
individual acceptor. Fig. 2a indicates that our experimental results are well in line 
with the Stern-Volmer equation. The KSV value shows that more than 1000 NPAFN 
molecules can be quenched by one NIR712 molecule, demonstrating the amplified 
energy transfer from NPAFN to NIR712. It is shown in Fig. 2b that the fluorescence 
intensity is greatly enhanced by almost 50 times when excited at 468 nm (~absorption 
peak of NPAFN) through FRET, in comparison to that obtained by direct excitation at 
680 nm (~ absorption peak of NIR712) under the same power density. Such 
prominent fluorescence amplification is attributed to the light harvesting ability of the 
NPAFN NPs and the subsequent efficient energy transfer to the doped NIR dyes. The 
NIR712 doped NPAFN NPs even exhibits 10 times stronger fluorescence than an 
equivalent amount of free NIR712 in THF solution excited at 680 nm, further 
indicating the amplified fluorescence emission. 
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3.4. Surface functionalization of NIR dye-doped NPs 
For a practical fluorescent probe, water-dispersibility and bio-environmental 
stability are essential requirements. We thus functionalized the NIR712-doped NPs 
with amphipathic surfactant C18PMH-PEG, a common surfactant used in 
bio-applications [27]. Since the NPs have hydrophobic surface properties, it is 
convenient that C18PMH-PEG will be anchored to them through hydrophobic 
interactions. This was confirmed by the comparing the FTIR spectra of 
NIR712-doped NPs and C18PMH-PEG modified NIR712-doped NPs (Fig. S4a). The 
figure shows that, after functionalization, the FTIR spectrum presents bands at around 
1100 cm-1 (indicated by a blue arrow) which are corresponding to the C-O-C 
stretching modes of PEG, indicating the existence C18PMH-PEG. After 
functionalization, we systematically studied the size and fluorescence intensity 
evolution of the NPs in a variety of environments including PBS, serum and solutions 
with pH = 2-10. Fig. S4b reveals that the size of the functionalized NPs still remained 
stable in different solutions after even 60 days. They also preserved strong 
photoluminescence in various environments (Fig. 2c). In marked comparison, the 
unmodified NPs were easy to aggregate with size significantly increased (Fig. S5a) 
and the fluorescence intensity quenched accordingly (Fig. S5b) within 30 minutes due 
to the damage of the surface charges by zwitterions in physiological saline. The total 
results demonstrate that surface functionalization by C18PMH-PEG can successfully 
endow the NPs with favorable water dispersibility and stability in various 
bio-environments, which makes the NPs suitable for in vitro and in vivo bioimaging. 
The results of the PL stability also prove that the NIR712 molecules are successfully 
loaded on the host material. 
 
3.5. Cytotoxicity 
Cytotoxicity of cell probes is crucial to their biomedical applications. To evaluate 
the cytotoxicity of NIR712-doped NPs before and after surface functionalization, 
standard MTT assays were performed on KB, HeLa and MRC-5 cell lines. As shown 
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in Fig. 2d and Fig. S6, these cell lines still retain high viabilities which are on average 
greater than 90% after 24 h incubation with the NPs of varied concentrations ranging 
from 0.6 to 20 μM, suggesting that the NPs have nearly negligible cell toxicity. 
 
3.6. In vitro targeted cell imaging 
The highly fluorescent and stable NIR-emissive NPs were further explored as a 
biological probe for in vitro imaging. To investigate the intracellular localization of 
the NPs, cells were dually labeled with blue nuclei-specific DAPI and green 
lysosome-specific Green DND-26. As shown in Fig. 3a, blue, green and red signals 
represent nuclei, lysosome and the NIR712-doped NPs respectively. It can be found 
that the fluorescence signal of the NPs is well overlapped with that of lysosome, 
indicating that NPs probes are primarily distributed in lysosome.  
Targeted cell imaging is very helpful to early cancer diagnosis. To achieve 
specific cancer cell targeting, one approach is to coat NPs with molecules which have 
strong affinity with the receptors expressed on cancer cells. As is well known, folate 
receptor (FR) is a widely studied cancer cell probe which is expressed on the surface 
of many types of cancer cells [28], so next we studied FR-mediated cell targeting. We 
firstly conjugated FA to the PEG terminals of C18PMH-PEG and then used the 
product to surface functionalize the NIR712-doped NPs. In the experiment, KB cells 
cultured in FA-free medium were considered as FR-positive cells because of their 
high FR expression. For comparison, KB cells cultured in normal medium were used 
as FR-negative controls because these cells have relatively low FR expression. Both 
types of KB cells were incubated with C18PMH-PEG and C18PMH-PEG-FA 
modified NIR712-doped NPs. Subsequently, cellular imaging was investigated using 
confocal laser scanning microscopy (CLSM) with a 488 nm laser excitation and the 
fluorescence was collected at wavelengths above 700 nm. In Fig. 3b, a strong red 
fluorescence is observed in FR-positive KB cells cultured with C18PMH-PEG-FA 
functionalized NPs, while rather weak signals are detected for FR-negative KB cells 
incubated with C18PMH-PEG functionalized NPs. Furthermore, when excessive free 
FA was used to block the FR on the KB cells, the fluorescence signals of the 
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C18PMH-PEG-FA functionalized NPs significantly dropped. Quantitative 
measurements from flow cytometry also verified the above phenomena. The 
fluorescence intensity of C18PMH-PEG-FA functionalized NPs in FR-positive cells 
was much stronger than that of other groups (Fig. 3c). These results clearly 
demonstrate the highly specific FR targeting of C18PMH-PEG-FA functionalized 
NIR712-doped NPs to FR-positive cancer cells. 
 
3.7. Photostability of NIR712-doped NPs 
High tolerance to photobleaching is one of the most important properties for a 
qualified fluorescent probe [16]. Therefore, we examined the photostability of the 
NIR712-doped NPs and compared with that of fluorescein isothiocyanate (FITC) dye 
under 488 nm laser illumination with confocal microscopy at same conditions. FITC 
is one of the most commonly used organic dyes in bioimaging. As shown in Fig. 4a, 
the green fluorescence of FITC dramatically fades after 2 min continuous laser 
irradiation and totally disappears after 10 min, owing to its severe photobleaching. In 
a sharp contrast, the red fluorescence of the doped NPs is still spatially resolved even 
with 60 min continuous laser irradiation under same recording conditions, although 
with signal intensity dropping. This result indicates that the NIR712-doped small 
organic NPs present much higher photostability than FITC. 
We further investigated the chemical stability of the doped NPs in vivo. Twenty 
microliters of 100 μM NPs were subcutaneously injected into the back of a Balb/c 
mouse. In vivo fluorescence imaging was carried out by a Maestro EX in vivo 
fluorescence imaging system (CRi, Inc.) and the signals were collected at 700-850 nm. 
Fig. 4b shows that the fluorescence signal of NPs in the injection site is bright red 
even at 96 h after subcutaneous injection. The result evidences that FRET in the 
doped NPs was not interfered by complex biological environment, and the surface 
functionalization successfully rendered the doped NPs with potent stability in various 
bio-environments with stable optical properties, which makes in vivo bioimaging 
feasible. 
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3.8. In vivo imaging and biodistribution 
The highly stable and bright NPs were then examined for in vivo bioimaging 
applications. The PEGylated NIR712-doped NPs (200 μL of 120 μM solution for each 
mouse) were intravenously injected into nude mice bearing KB tumor. Fig. S8 shows 
the time-dependent in vivo fluorescence imaging. There was notable fluorescence 
signals from the skin initially, however, the tumor site became more intense red and 
could be gradually distinguished from the autofluorescence of the mouse. At 48 h 
after injection, the fluorescence of the doped NPs was distinctively bright red and 
spatially resolved in the tumor site (Fig. 5b), indicating the preferential accumulation 
of the NPs in the tumor. The capacity of the NPs to selectively mark the tumor with an 
obvious contrast may be attributed to the combined effect of the bright fluorescence 
nature of the as-prepared NPs and the passive tumor-targeting delivery of 
nanomaterials to the tumor by enhanced permeability and retention (EPR) effect [29]. 
We next investigated the biodistribution profiles of the NPs by imaging a series 
of organs and the tumor of the mice at various time points after injection. Average 
fluorescence intensities of organs and tissues were calculated by a semiquantitative 
biodistribution analysis. Organs from a mouse without NP treatment were used as 
controls to subtract the autofluorescence background. Fig. 5c and d show that the 
doped NPs exhibited dominant uptake in the liver (67.5% ID g-1) at 1 h after 
intravenous injection. From 2 to 24 h, more and more NPs were taken up by tumor 
sites compared with other organs. At 48h post-injection, high levels of NPs were 
observed in the tumor (41.9% ID g-1) as well as the reticulo endothelial systems (RES) 
such as liver (39.3% ID g-1) and spleen (7.6% ID g-1), and only little amount of NPs 
was observed in intestine (4.2% ID g-1). All results distinctly indicate the potential 
application of using the doped NPs for in vivo imaging. 
 
3.9. Histology, biochemistry and hematology assay 
In vivo toxicity assessment of the doped NPs was then evaluated because it is 
also very important for their practical application. We assessed the systematic toxicity 
of the NPs by measuring body weight, hematology analysis, and blood biochemical 
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assay. Nine untreated mice were used as a control. In the experimental group of 9 
mice, 200 μL of 100 μM PEGylated NIR712-doped NPs was injected to each. No 
obvious body weight variation was observed for the mice after NP treatment (Fig. S9) 
compared with that of the control group. Another group of NP treated mice was 
sacrificed at Day 1, 7 and 14 for careful necropsy. Five representative organs 
including liver, kidney, spleen, lung, and heart of the mice were sectioned and stained 
by hematoxylin and eosin (H&E) for histology analysis (Fig. 6). In spite of relatively 
high RES uptake of the doped NPs in liver, no noticeable organ damage, 
inflammation and lesions were observed at Day 1, 7 and 14. Other organs of mice also 
showed no apparent histopathological abnormalities in comparison with those of the 
control mice. Histology results provide macroscopic and visual evidence of toxicity. 
To quantify the toxicity of the doped NPs, another important step is performing serum 
biochemistry and hematological assay. In the assay, the following standard 
hematology markers were selected for analysis: white blood cell count (WBC), mean 
corpuscular volume (MCV), red blood cell count (RBC), hematocrit (HCT), 
hemoglobin (HGB), mean corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), and platelet count (PLT). The results indicate 
that all measured factors of the NPs were within normal ranges and no apparent 
abnormalities were observed at Day 1, 7, and 14 (Fig. S10). Next, we measured a 
variety of factors (alkaline phosphatase (ALP), alanine aminotransferase (ALT), 
Aspartate aminotransferase (AST), blood urea nitrogen (BUN), creatinine (CRE), 
total protein (TP)) in the serum to assess liver function, hepatocellular injury, and 
kidney function. Almost all of the data fell within normal range (Fig. 7), suggesting 
that no obvious hepatic and kidney disorder of mice be induced by the NP injection. 
These data indicate that NIR712-doped NPs are not noticeably toxic to mice at the 
injected dose, which means that they could be a safe fluorescence probe for 
bioimaging. 
 
4. Conclusions 
We have demonstrated an approach of encapsulating NIR dyes into NPAFN NPs 
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to enable efficient FRET to achieve NIR emission for in vitro and in vivo imaging. 
Energy transfer from the host NPAFN NPs to the guest NIR712 molecules render this 
nanoprobe with large Stokes shift and amplified fluorescence emission. Furthermore, 
surface modification of the NPs with amphipathic surfactant endows them with water 
dispersity, stability and biocompatibility in various bio-environments. Last but not 
least, systematic in vivo toxicity studies indicate the favorable biocompatibility of the 
NIR712-doped ONPs. These superior properties enable the NIR-doped ONPs to be a 
potential probe for in vitro and in vivo imaging. 
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Figures and captions 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Characterization of NIR712-doped NPs: (a) SEM and TEM (inset) images; (b) Size 
distribution of the NPs by DLS measurement at 25 °C in water; (c) Normalized absorption 
(black line) spectrum of NIR dye/THF and fluorescence emission spectrum (red line) of 
NPAFN NPs; (d) Fluorescence spectra of NIR712-doped NPs at different doping 
concentrations. 
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Fig. 2. (a) Fluorescence quenching of donor versus molecule fraction of quenchers in 
NIR712-doped NPs. The scattered points represent the experimental results of the NPAFN 
fluorescence quenched by acceptors, and the solid line indicates the fit to the Stern-Volmer 
equation; (b) Normalized fluorescence peak intensities of NIR712-doped NPs and free 
NIR712 dye. For NIR712-doped NPs, excitation wavelength was set at 468 nm and 680 nm 
respectively, while the fluorescence of free NIR dyes was measured in THF with excitation 
wavelength of 680 nm; (c) Fluorescence intensity studies of NIR712-doped NPs treated with 
buffer solutions with pH values of 2 to 10, PBS and serum. Inset: fluorescence images of 
NIR712-doped NPs at Day 1 and Day 60; (d) MTT assay measured viabilities of KB cells 
incubated with NIR712-doped NPs and C18PMH-PEG modified NIR712-doped NPs of 
different concentrations for 24 h. 
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Fig. 3. (a) Confocal laser-scanning fluorescent microscopy images of normal KB cells 
incubated with (I) DAPI, (II) LysoTracker Green DND-26, (III) NIR712-doped NPs modified 
with C18PMH-PEG, (IV) Overlay of (I), (II) and (III). The scale bar indicates 20 μm; (b) 
Confocal laser-scanning fluorescent microscopy images of FR-positive KB cells incubated 
with NIR712-doped NPs modified with C18PMH-PEG-FA, FR-negative KB cells incubated 
with NIR712-doped NPs modified with C18PMH-PEG and FR-positive KB cells inhibition 
FA, then incubated with NIR712-doped NPs modified with C18PMH-PEG-FA respectively. 
The scale bar is 20 μm; (c) Flow cytometry detection of NIR712-doped NPs-labeled KB cells 
at same concentration; the colored lines show the fluorescence intensity distributions. Same 
volume of PBS was used as control group. 
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Fig. 4. (a) Fluorescence signals of KB cells labeled by NIR712-doped NPs (red) and FITC 
(green) at different time points. Scale bars are 10 μm; (b) Bright field picture and fluorescence 
images of a Balb/c mouse at 0, 24, and 96 h after subcutaneous injection of 20 μL of 100 μM 
NIR712-doped NPs. All fluorescence images were acquired with 100 ms exposure time. 
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Fig. 5. (a) Bright-field image of a KB-tumor-bearing nude mouse and NIR712-doped NP 
solution (inset); (b) In vivo fluorescence image of a mouse at 48 h after injection of the 
NIR712-doped NPs with 200 ms exposure time and the NIR712-doped NPs solution with 10 
ms exposure time (inset); (c) Semiquantitative biodistribution of the NIR712-doped NPs in 
mice determined by averaging the fluorescence intensity of each organ; Error bars were 
calculated from the data of three mice for each group; (d) Spectrally resolved ex vivo 
fluorescence images of organs before injection and at 1, 24, and 48 h after injection of the 
NIR712-doped NPs. Li: liver, M: muscle, Sk: skin, I: intestine, St: stomach, Lu: lung, H: 
heart, K: kidney, Sp: spleen, and T: tumor. All fluorescence images were acquired with 200 
ms exposure time.  
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Fig. 6. Liver, spleen, heart, lung and kidney histology images. Organs were stained with 
haematoxylin and eosin. 
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Fig. 7. Serum biochemistry data in blood at various time points after NIR712-doped NP 
treatment: (a) alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, (b) 
blood urea nitrogen, (c) creatinine, (d) total protein. Statistics were based on three mice per 
data point. 
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ToC figure 
 
 
 
 
 
 
 
 
 
 
 
We demonstrated an approach of encapsulating NIR dyes into red-emissive 
organic nanoparticles to enable efficient FRET and achieve NIR probes with large 
Stokes shift, amplified fluorescence emission, outstanding photo- and 
bio-environmental stability, and high biocompatibility for in vitro and in vivo imaging. 
All results prove the NIR-doped NPs can be a potential NIR fluorescent probe in 
biomedical applications. 
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Supplementary information 
 
 
 
 
 
 
Fig. S1. Molecular structure of NPAFN and NIR712. 
 
 
 
 
 
 
 
 
Fig. S2. Emission (λex = 680 nm) (a) and absorption (b) spectra of the filtrate. 
 
 
 
 
 
 
 
Fig. S3. Normalized absorption (black line) and emission (red line) spectra of NPAFN NPs 
(λex = 488 nm) (a), NIR712/THF (λex = 680 nm) (b), and (c) Absorption spectrum of 
NIR712-doped NPs. 
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Fig. S4. (a) FTIR spectra of NIR712-doped NPs and C18PMH-PEG modified NIR712-doped 
NPs; (b) Size studies of modified NIR712-doped NPs treated with serum, PBS, water and 
buffer solutions with pH values of 2 to 10. 
 
 
 
 
 
 
 
Fig. S5. (a) Size studies of unmodified NIR712-doped NPs in physiological saline within 30 
minutes; (b) PL intensity studies of unmodified NIR712-doped NPs treated with serum, PBS, 
water and buffer solutions with pH values of 2 to 10 within 7 days. 
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Fig. S6. Viabilities of (a) HeLa cells and (b) MRC-5 cells incubated with NIR712-doped NPs 
and C18PMH-PEG modified NIR712-doped NPs of different concentrations for 24 h. 
 
 
 
 
 
 
 
 
 
Fig. S7. Photostability of NIR712-doped NPs (in aqueous solution) and NIR712 (in THF). 
The samples were continuously irradiated by a 300 W xenon lamp. The concentrations of 
NIR712 remain the same in the two samples. After exposure to a very high density light (300 W 
xenon lamp and the OD = 0.5 w/cm2) for approximate 30 min, the fluorescence of NIR712 sharply 
decreased to about 30%. While in a distinct contrast, the NIR712-doped NPs displayed superior 
photostability, with the fluorescence intensity only reduced to 60 percent of the initial value within 
30 min irradiation. It indicates that the photostability of NIR712-doped NPs is improved compared 
with NIR712. 
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Fig. S8. Bright field image and in vivo fluorescence images of a mouse at 2 h, 12 h, 24 h and 
48 h after injection of NIR712-doped NPs. All fluorescence images were acquired with 200 
ms exposure time. 
 
 
 
 
 
 
 
 
 
Fig. S9. Normalized body weight curves of mice at different time points post injection. One 
group of mice was not treated and used as a control. The other group of mice was injected 
with 200 μL of 100 μM NIR712-doped NPs. 
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Fig. S10. Healthy female Balb/c mice intravenously injected with NIR712-doped NPs (200 
μL of 100 μM) were sacrificed at Day 1, 7 and 14 after injection for blood collection. 
Untreated healthy mice were used as the control. Hematology results: Blood levels of (a) 
white blood cells, (b) red blood cells, (c) hemoglobin, (d) hematocrit, (e) mean corpuscular 
volume, (f) mean corpuscular hemoglobin, (g) mean corpuscular hemoglobin concentration, 
(h) platelets. Statistics were based on three mice per data point. 
 
 
 
 
 
 
 
 
